Business Context and Reporting Period
This Form 8-K Current Report was filed by Immunome, Inc. (IMNM) on January 21, 2025. The company is incorporated in Delaware and operates as an emerging growth company. The report details a specific executive compensation arrangement rather than periodic financial results.
Key Financial Metrics
The filing does not provide standard financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The only financial data disclosed relates to a specific executive compensation package:
- Relocation Bonus: $100,000 one-time cash payment.
- Housing Bonus: $300,000 one-time cash payment contingent on purchasing a primary residence in the Bothell, Washington area.
Material Changes
The material event reported is the acceptance of a relocation package by Max Rosett, the Company's Chief Financial Officer, on January 21, 2025. This represents a new compensatory arrangement rather than a change in operational performance compared to a prior period.
Guidance, Outlook, and Contingencies
Contingencies and Repayment Obligations:
- Relocation Bonus: Subject to repayment if Mr. Rosett does not complete relocation by January 21, 2026, or if he does not remain employed for 90 days post-relocation.
- Housing Bonus: Subject to pro-rata repayment if Mr. Rosett does not remain employed for a three-year period after receipt.
- Exceptions: Repayment obligations are waived if Mr. Rosett resigns for "good reason" or is terminated without cause.
Outlook: The filing contains no forward-looking guidance regarding the company's business operations or financial outlook.
Key Facts for Investor Verification
- Verify the total potential cash outflow of $400,000 for the CFO relocation package.
- Confirm the specific definitions of "good reason" and "termination without cause" in the attached employment offer letter (Exhibit 10.1) to assess the likelihood of repayment.
- Note that the Housing Bonus is contingent on the purchase of a primary residence in a specific geographic area.
- Recognize that this filing does not contain updated financial statements or operational metrics.